The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations
Abstract
Somatic mutations in PRKACA, coding for the catalytic α subunit of protein kinase A (PKA), have been recently identified as the most frequent genetic alteration in cortisol-secreting adrenocortical adenomas, which are responsible for adrenal Cushing’s syndrome. The mutations identified so far lie at the interface between the catalytic (C) and regulatory (R) subunit of PKA. Detailed functional studies of the most frequent of these mutations (L206R) as well as of another one in the same region of the C subunit (199_200insW) have revealed that these mutations cause constitutive activation of PKA and lack of regulation by cAMP. This is due to interference with the binding of the R subunit, which keeps the C subunit inactive in the absence of cyclic AMP. Here, we review these recent findings, with a particular focus on the mechanisms of action of PRKACA mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, phosphoproteomic studies revealed significant changes in the phosphorylation profile of this oncogenic kinase, suggesting a reduction in the enzyme’s substrate fidelity [104, 105] and/or mislocalization [106].”
From An NMR portrait of functional and dysfunctional allosteric cooperativity in cAMP‐dependent protein kinase A (2023) · cites this paper as [105]
In the citing paper
“The cAMP/PKA pathway plays a central role in the regulation of adrenocortical growth and steroidogenesis [3, 4].”
From Is disrupted nucleotide-substrate cooperativity a common trait for Cushing'S syndrome driving mutations of protein kinase a? (2021) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
AKAP signalling complexes: focal points in space and time
Wong, W., & Scott, J. D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1527 · Cited by 1,073
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., & Vinson, G. P. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0326 · Cited by 600 · cited 1×
“Cortisol production by cells of the ZF is under strict control of the adrenocorticotropic hormone (ACTH) [45].”
BackgroundRegulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH
Simpson, E. R., & Waterman, M. R. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002235 · Cited by 506 · cited 1×
“This causes at least 2 temporally distinct responses in adrenocortical cells [52].”
BackgroundActivating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome
Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y., et al. (2014) · Science · doi:10.1126/science.1249480 · Cited by 232
Di Dalmazi, G., Kisker, C., Calebiro, D., Mannelli, M., Canu, L., Arnaldi, G., Quinkler, M., Rayes, N., Tabarin, A., Laure Jullié, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2152 · Cited by 119
60 YEARS OF POMC: Adrenal and extra-adrenal functions of ACTH
Gallo-Payet, N. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0257 · Cited by 98
Research works printed but not linked: 64
- K L Pierce, 2002, Seven-transmembrane receptors, Nat Rev Mol Cell Biol, 3, 639, 10.1038/nrm908 · DOI · Paper page
- S S Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat Rev Mol Cell Biol, 13, 646, 10.1038/nrm3432 · DOI · Paper page
- I Bossis, 2004, Minireview: PRKAR1A: Normal and Abnormal Functions, Endocrinology, 145, 5452, 10.1210/en.2004-0900 · DOI · Paper page
- A G Lania, 2006, Mechanisms of Disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases, Nat Clin Pract End Met, 2, 681, 10.1038/ncpendmet0324 · DOI
- J Lyons, 1990, Two G protein oncogenes in human endocrine tumors, Science, 249, 655, 10.1126/science.2116665 · DOI · Paper page
- J Parma, 1993, Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas, Nature, 365, 649, 10.1038/365649a0 · DOI · Paper page
- L Vallar, 1987, Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas, Nature, 330, 566, 10.1038/330566a0 · DOI · Paper page
- C A Landis, 1989, GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours, Nature, 340, 692, 10.1038/340692a0 · DOI · Paper page
- L S Weinstein, 1991, Activating mutations of the stimulatory G protein in the McCune-Albright syndrome, N Engl J Med, 325, 1688, 10.1056/NEJM199112123252403 · DOI · Paper page
- J A Carney, 2011, Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome, Am J Surg Pathol, 35, 1311, 10.1097/PAS.0b013e31821ec4ce · DOI
- S Espiard, 2014, Protein kinase A alterations in adrenocortical tumors, Horm Metab Res, 46, 869, 10.1055/s-0034-1385908 · DOI
- E L Greene, 2008, In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay, Hum Mutat, 29, 633, 10.1002/humu.20688 · DOI
- M Guillaud Bataille, 2014, Systematic screening for PRKAR1A gene rearrangement in Carney complex: identification and functional characterization of a new in-frame deletion, Eur J Endocrinol, 170, 151, 10.1530/EJE-13-0740 · DOI
- L Groussin, 2002, Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease, J Clin Endocrinol Metab, 87, 4324, 10.1210/jc.2002-020592 · DOI · Paper page
- E Meoli, 2008, Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors, Cancer Res, 68, 3133, 10.1158/0008-5472.CAN-08-0064 · DOI
- A Linglart, 2011, Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance, N Engl J Med, 364, 2218, 10.1056/NEJMoa1012717 · DOI · Paper page
- Y Rhayem, 2015, Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex, J Biol Chem, 290, 27816, 10.1074/jbc.M115.656553 · DOI
- E Szarek, 2014, Phosphodiesterases and Adrenal Cushing in Mice and Humans, Horm Metab Res, 46, 863, 10.1055/s-0034-1389916 · DOI
- P Salpea, 2014, Carney complex and McCune Albright syndrome: An overview of clinical manifestations and human molecular genetics, Mol Cell Endocrinol, 386, 85, 10.1016/j.mce.2013.08.022 · DOI
- F Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome, N Engl J Med, 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
- G Goh, 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors, Nat Genet, 46, 613, 10.1038/ng.2956 · DOI · Paper page
- Y Sato, 2014, Recurrent somatic mutations underlie corticotropin-independent Cushing’s syndrome, Science, 344, 917, 10.1126/science.1252328 · DOI · Paper page
- D A Johnson, 2001, Dynamics of cAMP-Dependent Protein Kinase, Chem Rev, 101, 2243, 10.1021/cr000226k · DOI · Paper page
- D Knighton, 1991, Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 407, 10.1126/science.1862342 · DOI · Paper page
- M Diskar, 2010, Regulation of cAMP-dependent Protein Kinases: The human protein kinase X (PrKX) reveals the role of the catalytic subunit aH-aI loop, J Biol Chem, 285, 35910, 10.1074/jbc.M110.155150 · DOI
- S S Taylor, 2013, PKA: lessons learned after twenty years, Biochim Biophys Acta, 1834, 1271, 10.1016/j.bbapap.2013.03.007 · DOI · Paper page
- D W Carr, 1991, Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with RII-anchoring proteins occurs through an amphipathic helix binding motif, J Biol Chem, 266, 14188, 10.1016/S0021-9258(18)98665-5 · DOI · Paper page
- F S Kinderman, 2006, A Novel and Dynamic Mechanism for AKAP Binding to RII Isoforms of cAMP-dependent Protein Kinase, Mol Cell, 24, 397, 10.1016/j.molcel.2006.09.015 · DOI · Paper page
- W Weber, 1979, Stoichiometry of cAMP binding and limited proteolysis of protein kinase regulatory subunits R I and R II, Biochem Biophys Res Commun, 90, 1073, 10.1016/0006-291X(79)91935-1 · doi:10.1016/0006-291x(79)91935-1
- S S Taylor, 1990, cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes, Annu Rev Biochem, 59, 971, 10.1146/annurev.bi.59.070190.004543 · DOI · Paper page
- P Zhang, 2012, Structure and Allostery of the PKA RIIb Tetrameric Holoenzyme, Science, 335, 712, 10.1126/science.1213979 · DOI · Paper page
- C Kim, 2007, PKA-I Holoenzyme Structure Reveals a Mechanism for cAMP-Dependent Activation, Cell, 130, 1032, 10.1016/j.cell.2007.07.018 · DOI · Paper page
- T J Sjoberg, 2010, Dissecting the cAMP-inducible allosteric switch in protein kinase A RIa, Protein Sci, 19, 1213, 10.1002/pro.400 · DOI
- C M Smith, 1999, The catalytic subunit of cAMP-dependent protein kinase: prototype for an extended network of communication, Prog Biophys Mol Biol, 71, 313, 10.1016/S0079-6107(98)00059-5 · DOI
- A C Bastidas, 2013, Phosphoryl transfer by protein kinase A is captured in a crystal lattice, J Am Chem Soc, 135, 4788, 10.1021/ja312237q · DOI · Paper page
- A C Bastidas, 2015, Molecular Features of Product Release for the PKA Catalytic Cycle, Biochemistry, 54, 2, 10.1021/bi500684c · DOI
- K Srivastava Atul, 2014, Synchronous Opening and Closing Motions Are Essential for cAMP-Dependent Protein Kinase A Signaling, Structure, 22, 1735, 10.1016/j.str.2014.09.010 · DOI · Paper page
- S S Taylor, 2004, PKA: a portrait of protein kinase dynamics, Biochim Biophys Acta, 1697, 259, 10.1016/j.bbapap.2003.11.029 · DOI · Paper page
- J Wu, 2007, PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity, Science, 318, 274, 10.1126/science.1146447 · DOI · Paper page
- J Arnold, 1866, Ein Beitrag zu der feineren Structur und dem Chemismus der Nebennieren, Arch Pathol Anatom Physiol Klin Med, 35, 64, 10.1007/BF01979887 · DOI
- T J Rosol, 2001, Adrenal Gland: Structure, Function, and Mechanisms of Toxicity, Toxicol Pathol, 29, 41, 10.1080/019262301301418847 · DOI · Paper page
- J Drouin, 2007, Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency, Clin Genet, 72, 175, 10.1111/j.1399-0004.2007.00877.x · DOI
- F Beuschlein, 2001, ACTH-receptor expression, regulation and role in adrenocortical tumor formation, Eur J Endocrinol, 144, 199, 10.1530/eje.0.1440199 · DOI
- I Kojima, 1985, Role of calcium and cAMP in the action of adrenocorticotropin on aldosterone secretion, J Biol Chem, 260, 4248, 10.1016/S0021-9258(18)89257-2 · DOI · Paper page
- A Weber, 1993, Functional Characterization of the Cloned Human ACTH Receptor: Impaired Responsiveness of a Mutant Receptor in Familial Glucocorticoid Deficiency, Biochem Biophys Res Commun, 197, 172, 10.1006/bbrc.1993.2456 · DOI
- C Kim, 2005, Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA, Science, 307, 690, 10.1126/science.1104607 · DOI · Paper page
- D M Stocco, 2005, Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought, Mol Endocrinol, 19, 2647, 10.1210/me.2004-0532 · DOI · Paper page
- M B Sewer, 2007, Transcriptional regulation of adrenocortical steroidogenic gene expression, Drug Metab Rev, 39, 371, 10.1080/03602530701498828 · DOI
- J C Chrivia, 1993, Phosphorylated CREB binds specifically to the nuclear protein CBP, Nature, 365, 855, 10.1038/365855a0 · DOI · Paper page
- D Rosenberg, 2002, Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues, Ann N Y Acad Sci, 968, 65, 10.1111/j.1749-6632.2002.tb04327.x · DOI · Paper page
- E H Cameron, 1968, The role of progesterone in the biosynthesis of cortisol in human adrenal tissue, J Endocrinol, 41, 319, 10.1677/joe.0.0410319 · DOI
- A J Clark, 2009, The genetics of familial glucocorticoid deficiency, Best Pract Res Clin Endocrinol Metab, 23, 159, 10.1016/j.beem.2008.09.006 · DOI
- D Chida, 2007, Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis, Proc Natl Acad Sci USA, 104, 18205, 10.1073/pnas.0706953104 · DOI · Paper page
- A P Coll, 2004, The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin, Endocrinology, 145, 4721, 10.1210/en.2004-0491 · DOI
- P J Hornsby, 1977, Hormonal-Control of Adrenocortical Cell-Proliferation - Desensitization to Acth and Interaction between Acth and Fibroblast Growth-Factor in Bovine Adrenocortical Cell-Cultures, J Clin Invest, 60, 342
- G E Mattos, 2011, Comparative effect of FGF2, synthetic peptides 1-28N-POMC and ACTH on proliferation in rat adrenal cell primary cultures, Cell Tissue Res, 345, 343, 10.1007/s00441-011-1220-8 · DOI
- J Karpac, 2005, Development, maintenance, and function of the adrenal gland in early postnatal proopiomelanocortin-null mutant mice, Endocrinology, 146, 2555, 10.1210/en.2004-1290 · DOI
- M Fassnacht, 2003, N-Terminal Proopiomelanocortin Acts as a Mitogen in Adrenocortical Tumor Cells and Decreases Adrenal Steroidogenesis, J Clin Endocrinol Metab, 88, 2171, 10.1210/jc.2002-021318 · DOI
- D Calebiro, 2014, PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit, Nat Commun, 5, 5680, 10.1038/ncomms6680 · DOI · Paper page
- D Calebiro, 2015, cAMP signaling in cortisol producing adrenal adenoma, Eur J Endocrinol, 173, M99, 10.1530/EJE-15-0353 · DOI · Paper page
- R M Gibson, 1997, Dissecting the Cooperative Reassociation of the Regulatory and Catalytic Subunits of cAMP-dependent Protein Kinase: Role of Trp-196 in the catalytic subunit, J Biol Chem, 272, 31998, 10.1074/jbc.272.51.31998 · DOI · Paper page
- J N Honeyman, 2014, Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
- J Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, Proc Natl Acad Sci USA, 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
- R Rock, 2015, Impact of kinase activating and inactivating patient mutations on binary PKA interactions, Front Pharmacol, 6, 170
Cited by
Walker, C., Wang, Y., Olivieri, C., V.S, M., Gao, J., Bernlohr, D. A., Calebiro, D., Taylor, S. S., & Veglia, G. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167123 · Cited by 25
Self-citationOlivieri, C., Wang, Y., Walker, C., Subrahmanian, M. V., Ha, K. N., Bernlohr, D., Gao, J., Camilloni, C., Vendruscolo, M., Taylor, S. S., et al. (2024) · eLife · doi:10.7554/elife.91506.3 · Cited by 18
Olivieri, C., Walker, C., Veliparambil Subrahmanian, M., Porcelli, F., Taylor, S. S., Bernlohr, D. A., & Veglia, G. (2023) · FEBS Letters · doi:10.1002/1873-3468.14610 · Cited by 10
Metadata
- Authors
- Calebiro, D., Bathon, K., & Weigand, I.
- Affiliations
- Institute of Pharmacology and Toxicology, University Hospital, University of Würzburg, Würzburg, Germany
- Department of Medicine I, Endocrine and Diabetes Unit, University Hospital, University of Würzburg, Würzburg, Germany
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 2016-11-03
- Volume
- 49
- Issue
- 04
- Pages
- 307-314
- ISSN
- 0018-5043
- 1439-4286
- Cited by
- 19
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations. https://app.cochat.ai/papers/10.1055/s-0042-112817
- The paper
- Calebiro, D., Bathon, K., & Weigand, I. (2017). Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations. Hormone and Metabolic Research. https://doi.org/10.1055/s-0042-112817
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.